PK Study of Sotagliflozin in Subjects With Hepatic Impairment

Inclusion Criteria: * Adult male and female subjects ≥18 to ≤70 years of age * Body mass index ≥18.0 to ≤36.0 kg/m2, inclusive, at Screening * Subjects with mild, moderate, or severe hepatic impairment * Control group of matched healthy subjects * Willing and able to provide written informed consent Exclusion Criteria: * Presence of clinically significant physical, laboratory, or ECG findings that may interfere with any aspect of study conduct or interpretation of results * Existence of any surgical or medical condition that might interfere with the absorption, distribution, metabolism, or excretion of sotagliflozin * History of any major surgery within 6 months * History of renal disease, or significantly abnormal kidney function test * Women who are breastfeeding or are planning to become pregnant during the study